Pemetrexed in Recurrent or Progressive Central Nervous System Lymphoma: A Phase I Multicenter Clinical Trial

LESSONS LEARNED: The findings from this study using monotherapy with pemetrexed in a pretreated patient population are, overall, encouraging. Unlike high‐dose methotrexate, which requires several days of inpatient hospitalization, pemetrexed is relatively easy to administer in the outpatient setting...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncologist
Autori principali: Dietrich, Jorg, Versmee, Laura, Drappatz, Jan, Eichler, April F., Nayak, Lakshmi, Norden, Andrew, Wong, Eric, Pisapia, Michelle R., Jones, SooAe S., Gordon, Amanda B., Chabner, Bruce A., Hochberg, Fred, Batchelor, Tracy T.
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley & Sons, Inc. 2020
Soggetti:
Clinical Trial Results
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7485351/
https://ncbi.nlm.nih.gov/pubmed/32520407
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2020-0489
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi